PROCEPT BioRobotics (PRCT) EPS (Basic) Growth (1y) (2021 - 2026)
PROCEPT BioRobotics (PRCT) EPS (Basic) Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.55 Bn | 176.26 Bn | 6.27 Bn | -18.87% |
| 2 | Stryker | 128.64 Bn | 125.76 Bn | 3.81 Bn | 13.56% |
| 3 | Medtronic | 108.92 Bn | 99.70 Bn | 6.41 Bn | 18.90% |
| 4 | Boston Scientific | 68.50 Bn | 67.05 Bn | 3.61 Bn | 97.93% |
| 5 | Edwards Lifesciences | 47.84 Bn | 44.17 Bn | 1.29 Bn | - |
| 6 | GE HealthCare Technologies | 28.25 Bn | 25.96 Bn | 1.98 Bn | -29.95% |
| 7 | Dexcom | 28.23 Bn | 27.11 Bn | 750.30 Mn | 92.23% |
| 8 | Smith & Nephew | 26.93 Bn | 26.35 Bn | - | - |
| 9 | Koninklijke Philips | 25.43 Bn | 22.30 Bn | 2.07 Bn | 114.97% |
| 10 | PROCEPT BioRobotics | 1.01 Bn | 760.25 Mn | 53.95 Mn | -24.29% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -24.29% |
| Dec 31, 2025 | -48.24% |
| Sep 30, 2025 | -61.76% |
| Jun 30, 2025 | -79.00% |
| Mar 31, 2025 | 44.69% |
| Dec 31, 2024 | 38.93% |
| Sep 30, 2024 | -8.39% |
| Jun 30, 2024 | 37.16% |
| Mar 31, 2024 | 52.92% |
| Dec 31, 2023 | -20.26% |
| Sep 30, 2023 | 29.81% |
| Jun 30, 2023 | -123.80% |
| Mar 31, 2023 | -286.30% |
| Dec 31, 2022 | 51.30% |
| Sep 30, 2022 | 42.82% |
| Jun 30, 2022 | 83.33% |
| Mar 31, 2022 | 83.11% |
| Dec 31, 2021 | 70.33% |
| Sep 30, 2021 | 45.77% |